Bongaarts, A. Et Al. 2017. Subependymal giant cell astrocytomas in Tuberous Sclerosis Complex have consistent TSC1/TSC2 biallelic inactivation, and no BRAF mutations. ONCOTARGET , vol.8, no.56 , 95516-95529.

Bongaarts, A., Giannikou, K., Reinten, R. J., Anink, J. J., Mills, J. D., Jansen, F. E., ... Spliet, W. G. M.(2017). Subependymal giant cell astrocytomas in Tuberous Sclerosis Complex have consistent TSC1/TSC2 biallelic inactivation, and no BRAF mutations. ONCOTARGET , vol.8, no.56, 95516-95529.

Bongaarts, Anika Et Al. "Subependymal giant cell astrocytomas in Tuberous Sclerosis Complex have consistent TSC1/TSC2 biallelic inactivation, and no BRAF mutations," ONCOTARGET , vol.8, no.56, 95516-95529, 2017

Bongaarts, Anika Et Al. "Subependymal giant cell astrocytomas in Tuberous Sclerosis Complex have consistent TSC1/TSC2 biallelic inactivation, and no BRAF mutations." ONCOTARGET , vol.8, no.56, pp.95516-95529, 2017

Bongaarts, A. Et Al. (2017) . "Subependymal giant cell astrocytomas in Tuberous Sclerosis Complex have consistent TSC1/TSC2 biallelic inactivation, and no BRAF mutations." ONCOTARGET , vol.8, no.56, pp.95516-95529.

@article{article, author={Anika Bongaarts Et Al. }, title={Subependymal giant cell astrocytomas in Tuberous Sclerosis Complex have consistent TSC1/TSC2 biallelic inactivation, and no BRAF mutations}, journal={ONCOTARGET}, year=2017, pages={95516-95529} }